Summary
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
The global Tyrosine Kinase JAK Inhibitors market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Pfizer
Incyte
Novartis
Eli Lilly
Gilead
Sanofi
Sanofi
AbbVie
Vertex
Teva
Astellas Pharma
Celgene
CTI BioPharma
Major applications as follows:
Rheumatoid Arthritis (RA)
Polycythemia Vera (PCV)
Myelofibrosis (MF)
Others
Major Type as follows:
Tofacitinib
Ruxolitinib
Baricitinib
Regional market size, production data and Trade:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Pfizer
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Incyte
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Novartis
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Eli Lilly
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Gilead
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Sanofi
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Sanofi
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 AbbVie
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Vertex
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Teva
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Astellas Pharma
3.12 Celgene
3.13 CTI BioPharma
4 Major Application
4.1 Rheumatoid Arthritis (RA)
4.1.1 Overview
4.1.2 Rheumatoid Arthritis (RA) Market Size and Forecast
4.2 Polycythemia Vera (PCV)
4.2.1 Overview
4.2.2 Polycythemia Vera (PCV) Market Size and Forecast
4.3 Myelofibrosis (MF)
4.3.1 Overview
4.3.2 Myelofibrosis (MF) Market Size and Forecast
4.4 Others
4.4.1 Overview
4.4.2 Others Market Size and Forecast
5 Market by Type
5.1 Tofacitinib
5.1.1 Overview
5.1.2 Tofacitinib Market Size and Forecast
5.2 Ruxolitinib
5.2.1 Overview
5.2.2 Ruxolitinib Market Size and Forecast
5.3 Baricitinib
5.3.1 Overview
5.3.2 Baricitinib Market Size and Forecast
6 Conclusion
List of Table
Tab Regional Production 2011-2017 (Million USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of Incyte
Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis
Tab Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly
Tab Sales Revenue, Volume, Price, Cost and Margin of Gilead
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Tab Sales Revenue, Volume, Price, Cost and Margin of AbbVie
Tab Sales Revenue, Volume, Price, Cost and Margin of Vertex
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva
Tab Sales Revenue, Volume, Price, Cost and Margin of Astellas Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Celgene
Tab Sales Revenue, Volume, Price, Cost and Margin of CTI BioPharma
List of Figure
Fig Global Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2011-2017 (Million USD)
Fig Global Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2011-2017 (Volume)
Fig Global Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Fig Rheumatoid Arthritis (RA) Market Size and CAGR 2011-2017 (Million USD)
Fig Rheumatoid Arthritis (RA) Market Size and CAGR 2011-2017 (Volume)
Fig Rheumatoid Arthritis (RA) Market Forecast and CAGR 2018-2025 (Million USD)
Fig Rheumatoid Arthritis (RA) Market Forecast and CAGR 2018-2025 (Volume)
Fig Polycythemia Vera (PCV) Market Size and CAGR 2011-2017 (Million USD)
Fig Polycythemia Vera (PCV) Market Size and CAGR 2011-2017 (Volume)
Fig Polycythemia Vera (PCV) Market Forecast and CAGR 2018-2025 (Million USD)
Fig Polycythemia Vera (PCV) Market Forecast and CAGR 2018-2025 (Volume)
Fig Myelofibrosis (MF) Market Size and CAGR 2011-2017 (Million USD)
Fig Myelofibrosis (MF) Market Size and CAGR 2011-2017 (Volume)
Fig Myelofibrosis (MF) Market Forecast and CAGR 2018-2025 (Million USD)
Fig Myelofibrosis (MF) Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Tofacitinib Market Size and CAGR 2011-2017 (Million USD)
Fig Tofacitinib Market Size and CAGR 2011-2017 (Volume)
Fig Tofacitinib Market Forecast and CAGR 2018-2025 (Million USD)
Fig Tofacitinib Market Forecast and CAGR 2018-2025 (Volume)
Fig Ruxolitinib Market Size and CAGR 2011-2017 (Million USD)
Fig Ruxolitinib Market Size and CAGR 2011-2017 (Volume)
Fig Ruxolitinib Market Forecast and CAGR 2018-2025 (Million USD)
Fig Ruxolitinib Market Forecast and CAGR 2018-2025 (Volume)
Fig Baricitinib Market Size and CAGR 2011-2017 (Million USD)
Fig Baricitinib Market Size and CAGR 2011-2017 (Volume)
Fig Baricitinib Market Forecast and CAGR 2018-2025 (Million USD)
Fig Baricitinib Market Forecast and CAGR 2018-2025 (Volume)
